COMMUNIQUÉS West-GlobeNewswire

-
Sabin Sends More Marburg Vaccines for Rwanda’s Outbreak
31/10/2024 -
KFSHRC Leads Ethical Integration of AI in Healthcare
31/10/2024 -
GUERBET : Financial agenda for 2025
31/10/2024 -
GUERBET : Calendrier financier de l'exercice 2025
31/10/2024 -
Monica Lewinsky Visits Agnivesh Agarwal’s Primeks Medical, Advocates Against Cyberbullying in Istanbul
31/10/2024 -
Director/PDMR Shareholding
31/10/2024 -
Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs
31/10/2024 -
Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC)
31/10/2024 -
AMN Healthcare Names Tomya Watt as Chief People Officer
31/10/2024 -
Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, Spain
31/10/2024 -
Hormonic Unveils All-in-One Platform to Revolutionize Women’s Hormonal Health
31/10/2024 -
WAKE RADIOLOGY TO HOST LUNG CANCER SCREENING EVENT SATURDAY, NOVEMBER 9
31/10/2024 -
Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs
31/10/2024 -
HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024
31/10/2024 -
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates
31/10/2024 -
Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024
31/10/2024 -
MiNK Therapeutics Announces Appointment of Dr. Robert Kadlec to Board of Directors
31/10/2024 -
NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
31/10/2024 -
Sharecare expands suite of interactive media solutions to engage, educate, and activate patients and providers
31/10/2024
Pages